Multidisciplinary Epidemiology and Translational Research in Intensive Care, Mayo Clinic College of Medicine, Rochester, MN, USA.
Intensive Care Med. 2009 Dec;35(12):2087-95. doi: 10.1007/s00134-009-1635-9. Epub 2009 Sep 15.
The Risk, Injury, Failure, Loss and ESRD (RIFLE) classification has been widely accepted for the definition of acute kidney injury (AKI); however, no study has described in detail the last two stages of the classification: "Loss" and "ESRD". We aim to describe and evaluate the development of "Loss" and "ESRD" in a group of critically ill patients.
We conducted a retrospective analysis of cases prospectively collected from the Acute Physiology and Chronic Health Assessment (APACHE III) database. Subjects were consecutive critically ill patients >18 years of age admitted to three ICUs of two tertiary care academic hospitals, from January 2003 through August 2006, excluding those who denied research authorization, chronic hemodialysis therapy, kidney transplant recipients, readmissions, and admissions for less than 12 h for low risk monitoring.
11,644 patients were included in the study. The median age was 66 (interquartile range, 52-76), 90% were Caucasians and 54% of the patients were male. Half of the patients developed AKI, and most of the patients were in the Risk and Injury stages. From the patients that developed AKI, a total of 1,065 (19%) patients required renal replacement therapy (RRT), 415 (39%) underwent continuous renal replacement therapy (CRRT) and 650 (61%) underwent intermittent hemodialysis. A total of 281 patients on RRT did not survive hospital discharge, 97 patients progressed to "Loss", and 282 patients progressed to "ESRD". After multivariable adjustment, the progression to "ESRD" was associated with higher baseline creatinine, odds ratio (OR) 1.19 per every increase in creatinine of 0.1 mg/dl (95% CI, 1.11-1.29) P < 0.001; and less frequent use of CRRT, OR 0.18 (95% CI, 0.11-0.29) P < 0.001.
In this large retrospective study we found that almost 50% developed some form of AKI as defined by the RIFLE classification. Of these, 19% required RRT, and 4.9% progressed to "ESRD". "ESRD" was more likely in patients with elevated baseline creatinine and those treated with intermittent hemodialysis.
风险、损伤、衰竭、丧失和终末期肾病(RIFLE)分类已被广泛用于定义急性肾损伤(AKI);然而,尚无研究详细描述该分类的最后两个阶段:“丧失”和“终末期肾病”。我们旨在描述和评估一组危重病患者中“丧失”和“终末期肾病”的发展情况。
我们对 2003 年 1 月至 2006 年 8 月期间从两家三级学术医院的三个 ICU 连续收集的病例进行了回顾性分析。受试者为年龄>18 岁的连续危重病患者,排除了拒绝研究授权、慢性血液透析治疗、肾移植受者、再入院和因低风险监测而入院不足 12 小时的患者。
共有 11644 例患者纳入研究。中位年龄为 66 岁(四分位距,52-76),90%为白种人,54%的患者为男性。一半的患者发生 AKI,大多数患者处于风险和损伤阶段。在发生 AKI 的患者中,共有 1065 例(19%)需要肾脏替代治疗(RRT),415 例(39%)接受连续肾脏替代治疗(CRRT),650 例(61%)接受间歇性血液透析。共有 281 例 RRT 患者未存活出院,97 例进展为“丧失”,282 例进展为“终末期肾病”。多变量调整后,进展为“终末期肾病”与基线肌酐升高相关,每增加 0.1mg/dl 的肌酐,比值比(OR)为 1.19(95%置信区间,1.11-1.29),P<0.001;以及较少使用 CRRT,OR 0.18(95%置信区间,0.11-0.29),P<0.001。
在这项大型回顾性研究中,我们发现几乎 50%的患者按照 RIFLE 分类定义发生了某种形式的 AKI。其中,19%需要 RRT,4.9%进展为“终末期肾病”。基线肌酐升高和接受间歇性血液透析治疗的患者更有可能进展为“终末期肾病”。